Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sanofi Aventis Maps Out India R&D Strategy To Broaden Reach Into Untapped Markets

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - For the last five years, the Indian affiliate of French drug giant Sanofi Aventis has been working very quietly, assiduously integrating the operations of the two companies that turned into a single entity as part of a mega-deal in 2004 and then drawing up its rollout program under the newly christened identity

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts